|

Androgen deprivation therapy (ADT) Clinical Trials

12 actively recruiting trials across 6 locations

Pipeline

Phase 2: 7Phase 3: 2Phase 2/3: 2

Top Sponsors

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2
  • Affidea Nu-med Center of Oncological DIagnostics and Therapy2
  • University of Texas Southwestern Medical Center1
  • University of Maryland, Baltimore1
  • University of Chicago1

Indications

  • Cancer12
  • Prostate Cancer9
  • Dose Escalation: Solid Tumors2
  • Stereotactic Body Radiation Therapy (SBRT)2
  • Biochemical Recurrence2

Other6 trials

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
Phase 3
Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)
Phase 2
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
Phase 2/3
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
Phase 2/3
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Phase 2
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Phase 2

Phoenix, Arizona1 trial

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site

Phase 3

Chicago, Illinois1 trial

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

UChicago Medicine Comprehensive Cancer Center

Phase 2

Baltimore, Maryland1 trial

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

University of Maryland Greenebaum Cancer Center

Phase 2

New York, New York1 trial

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

NYU Langone Health

N/A

Cleveland, Ohio1 trial

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

University Hospitals Cleveland Medical Center Seidman Cancer Center

Phase 2

Dallas, Texas1 trial

Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

UT Southwestern Medical Center-Dallas

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.